Progress in Cardiovascular Diseases
Volume 53, Issue 1 , Pages 39-44 , July 2010

Blood Pressure and Cardiovascular Disease: Tracing the Steps From Framingham

  • Fiona Turnbull

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Fiona Turnbull, MBChB, MPH (Hons), FAFPHM, PhD, Acting Director, Cardiovascular Division, The George Institute for International Health, PO Box M201, Missenden Rd, Camperdown, NSW 2050, Australia.
    • ,
  • Andre Pascal Kengne
    • ,
  • Stephen MacMahon

References 

  1. Murray C, Lopez A. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet. 1997;349:1269–1276
  2. Lopez A, Mathers C, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367:1747–1757
  3. World Health Organisation . World Health Report 2002; reducing risk, promoting healthy life. Geneva: World Health Organisation; 2002;
  4. Lawes C, Vander Hoorn S, Rodgers A for the International Society of Hypertension. Global burden of blood pressure-related heart disease, 2001. Lancet. 2008;371:1513–1518
  5. In:  Ruskin A editors. Classics in arterial hypertension. Springfield, IL: Charles C Thomas; 1956;
  6. Rutan GH, McDonald RH, Kueller LH. A historical perspective of elevated systolic vs diastolic blood pressure from an epidemiological and clinical trial viewpoint. J Clin Epidemiol. 1989;42:663–673
  7. In:  Cecil R,  Kennedy F editor. A text book of medicine. Philadelphia: Saunders; 1927;
  8. Kannel W, Schwartz M. Blood pressure and Risk of Coronary Heart Disease: the Framingham Study. Dis Chest. 1969;56:43–52
  9. Dawber T, Meadors G, Moore F. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41:279–286
  10. Dawber T, Moore F. Longitudinal study of heart disease in Framingham, Massachusetts: an interim report. In: Annual conference of the Milbank Memorial Fund: research in public health. 1951;p. 241–247
  11. Kannel W. Role of blood pressure in cardiovascular morbidity and mortality. Prog Cardiovasc Dis. 1974;XVII:5–24
  12. Morris J, Kagan A, Pattison D, et al. Incidence and prediction of ischemic heart disease in London busmen. Lancet. 1966;2:553–559
  13. Gubner R. Systolic hypertension: a pathogenetic entity. significance and therapeutic considerations. Am J Cardiol. 1962;9:773–776
  14. Pickering G. Hypertension: natural history, diagnosis, prognosis and management. Med Times. 1965;93:939
  15. Colandrea M, Friedman G, Nichaman M, et al. Systolic hypertension in the elderly. An epidemiologic assessment. Circulation. 1970;41:239–245
  16. Kannel W, Wolf P, Verter J, et al. Epidemiologic assessment of the role of blood pressure in stroke. The Framingham Study. JAMA. 1970;214:301–310
  17. Kannel W, Dawber T, Sorlie P, et al. Components of blood pressure and risk of atherothrombotic brain infarction; the Framingham study. Stroke. 1976;7:327–331
  18. Shea S, Cook F, Kannel W, et al. Treatment of hypertension and its effect on cardiovascular risk factors: data from the Framingham Heart Study. Circulation. 1985;1:22–30
  19. Gordon T, Garcia-Palmieri M, Kagan A, et al. Differences in coronary heart disease in Framingham, Honolulu and Puerto Rico. J Chron Dis. 1974;27:329–344
  20. Cruickshank J. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ. 1988;297:1227–1230
  21. Cruickshank JM, Thorp JM, Zacharias FJ. Benefits and potential harm of lowering high blood pressure. Lancet. 1987;581–584
  22. D'Agostino R, Belanger A, Kannel W, et al. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham study. BMJ. 1991;303:385–389
  23. MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765–774
  24. Kannel W, Wilson P, Nam BH, et al. A likely explanation for the J-curve of blood pressure and cardiovascular risk. Am J Cardiol. 2004;94:380–384
  25. Lewington S, Thomsen T, Davidsen M, et al. Regression dilution bias in blood total and high-density lipoprotein cholesterol and blood pressure in the Glostrup and Framingham prospective studies. J Cardiovasc Risk. 2003;10:143–148
  26. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913
  27. Kannel W. Risk stratification in hypertension: new insights from the Framingham study. Am J Hypertens. 2000;13:3S–10S
  28. Wilson P, D'Agnostino R, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847
  29. D'Agnostino R, Vasan R, Pencina M, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743–753
  30. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood pressure lowering regimens on major cardiovascular events: second cycle of prospectively designed overviews. Lancet. 2003;362:1527–1535
  31. Kearney P, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–223

 Statement of Conflict of Interest: see page 43.

PII: S0033-0620(10)00054-X

doi: 10.1016/j.pcad.2010.03.002

Progress in Cardiovascular Diseases
Volume 53, Issue 1 , Pages 39-44 , July 2010

Article Tools

* Image Usage & Resolution